![Gina M. Wallar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gina M. Wallar
Keine laufenden Positionen mehr
Profil
Gina M.
Wallar worked as a Director at LabCorp Clinical Trials.
She then worked at NeoGenomics, Inc. as the President-Pharma Services Division from 2021 to 2022.
Dr. Wallar holds a doctorate degree from the University of California, Los Angeles.
Ehemalige bekannte Positionen von Gina M. Wallar
| Unternehmen | Position | Ende |
|---|---|---|
| NEOGENOMICS, INC. | Corporate Officer/Principal | 27.05.2022 |
LabCorp Clinical Trials
 LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Direktor/Vorstandsmitglied | - |
Ausbildung von Gina M. Wallar
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
NeoGenomics, Inc.
 NeoGenomics, Inc. Medical/Nursing ServicesHealth Services Provides genetic and molecular testing services | Health Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LabCorp Clinical Trials
LabCorp Clinical Trials Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
